ACESO LIFE SCI (00474): Completion of loan agreement refinancing arrangement.

date
28/09/2025
avatar
GMT Eight
Sinomab Life Sciences Technology (00474) announced the refinancing arrangement related to the 2018 financing agreement. By 2025...
ACESO LIFE SCI (00474) announced the refinancing arrangement for the 2018 financing agreement. All conditions precedent under the 2025 loan agreement have been met, and completion of delivery was on September 26, 2025. With the completion of this delivery, the company has been provided with a total financing amount of approximately 87.3 million, of which approximately 70.3 million has been drawn down today to fully repay the UK loans and related transaction costs. The remaining 17 million will be used for capital expenditures for the company's UK properties over the next one to two years. The company will begin planning for a large-scale renovation project on its UK properties, including upgrading its main facilities and ancillary facilities, in order to increase rental income and capital value of the UK properties.